Does pre-existing cognitive impairment no-dementia influence the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia?

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1412-4. doi: 10.1136/jnnp-2013-305281. Epub 2013 Aug 2.
No abstract available

Keywords: CEREBROVASCULAR DISEASE; COGNITION; DEMENTIA; STROKE.

Publication types

  • Controlled Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravenous
  • Aged
  • Brain Ischemia / complications
  • Brain Ischemia / drug therapy*
  • Case-Control Studies
  • Cognition Disorders / complications
  • Cognition Disorders / drug therapy*
  • Dementia / diagnosis
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator